The JOIC is a part of the Jersey Data Protection Authority and is responsible for overseeing the data protection and freedom of information laws.

During its audit process the JOIC assesses policies, processes and levels of compliance with data protection law, highlight potential risks and set timeframes for improvements. The most recent audit follows a separate review of part of the island’s health sector in March.

“Organisations should be getting the basics right to avoid breaches which can cause distress and harm to individuals and reputational damage,” Mr Vane said. “Elements of this most recent audit mirror the findings from a separate audit on a health service sector that we published earlier this year.

“We publish key findings to allow those processing personal information in Jersey, no matter how small or large their organisation, to benefit from the lessons learned.

“We hope lessons from our audits as well as other enforcement actions send a very strong message to those operating in Jersey that are entrusted with islanders’ personal information.”

an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced the extension of its collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company. This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches.

Merck KGaA, Darmstadt, Germany will now further leverage Quris-AI platform’s ability to effectively identify liver toxicity risks in a selection of drug candidates. Subsequently, Merck KGaA, Darmstadt, Germany has the option to obtain up to a five-year exclusive license to a specific disease domain. Upon Merck KGaA, Darmstadt, Germany exercising the option, Quris-AI may receive an undisclosed amount.